Primary |
Type 2 Diabetes Mellitus |
30.2% |
Diabetes Mellitus |
22.1% |
Product Used For Unknown Indication |
16.2% |
Hypertension |
10.8% |
Drug Use For Unknown Indication |
6.9% |
Diabetes Mellitus Non-insulin-dependent |
2.2% |
Insomnia |
1.2% |
Diabetes |
1.0% |
Hypothyroidism |
1.0% |
Cardiovascular Event Prophylaxis |
0.9% |
Blood Pressure |
0.8% |
Constipation |
0.8% |
Diabetes Mellitus Inadequate Control |
0.8% |
Hyperglycaemia |
0.8% |
Hypertensive Cardiomyopathy |
0.8% |
Schizoaffective Disorder |
0.8% |
Sciatica |
0.8% |
Blood Glucose Increased |
0.7% |
Dyslipidaemia |
0.7% |
Hypercholesterolaemia |
0.7% |
|
Hypoglycaemia |
21.7% |
Renal Failure Acute |
8.7% |
Vomiting |
5.6% |
Nausea |
5.0% |
Pharmaceutical Product Complaint |
5.0% |
Unresponsive To Stimuli |
5.0% |
Weight Increased |
5.0% |
Blood Glucose Increased |
3.7% |
Chest Pain |
3.7% |
Pneumonia |
3.7% |
Rash |
3.7% |
Renal Failure |
3.7% |
Tooth Loss |
3.7% |
Vision Blurred |
3.7% |
Bladder Cancer |
3.1% |
Loss Of Consciousness |
3.1% |
Pancreatitis Acute |
3.1% |
Tachycardia |
3.1% |
Wrong Drug Administered |
3.1% |
Anaphylactic Reaction |
2.5% |
|
Secondary |
Type 2 Diabetes Mellitus |
34.1% |
Diabetes Mellitus |
15.8% |
Product Used For Unknown Indication |
14.9% |
Drug Use For Unknown Indication |
11.9% |
Hypertension |
6.8% |
Diabetes Mellitus Non-insulin-dependent |
3.5% |
Acute Myocardial Infarction |
2.0% |
Depression |
1.3% |
Dyslipidaemia |
1.3% |
Rheumatoid Arthritis |
1.0% |
Cardiac Failure |
0.9% |
Hypercholesterolaemia |
0.9% |
Back Pain |
0.8% |
Coronary Artery Disease |
0.8% |
Schizoaffective Disorder |
0.8% |
Atrial Fibrillation |
0.7% |
Hiv Infection |
0.7% |
Hypothyroidism |
0.6% |
Pain |
0.6% |
Type 1 Diabetes Mellitus |
0.6% |
|
Hypoglycaemia |
13.1% |
Blood Glucose Increased |
10.4% |
Renal Failure Acute |
8.1% |
Nausea |
7.0% |
Weight Decreased |
7.0% |
Hypoglycaemic Coma |
5.7% |
Pancreatitis Acute |
5.7% |
Tachycardia |
5.0% |
Vomiting |
5.0% |
Drug Ineffective |
4.0% |
Overdose |
4.0% |
Weight Increased |
4.0% |
Pancreatitis |
3.7% |
Completed Suicide |
3.4% |
Toxicity To Various Agents |
2.7% |
Death |
2.3% |
Liver Disorder |
2.3% |
Lung Neoplasm Malignant |
2.3% |
Alanine Aminotransferase Increased |
2.0% |
Drug Interaction |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
21.5% |
Diabetes Mellitus |
16.9% |
Type 2 Diabetes Mellitus |
14.6% |
Drug Use For Unknown Indication |
13.3% |
Hypertension |
10.8% |
Rheumatoid Arthritis |
3.3% |
Prophylaxis |
2.1% |
Blood Cholesterol Increased |
2.0% |
Pain |
2.0% |
Diabetes Mellitus Non-insulin-dependent |
1.7% |
Depression |
1.6% |
Blood Pressure |
1.4% |
Atrial Fibrillation |
1.4% |
Gastrooesophageal Reflux Disease |
1.3% |
Cardiac Disorder |
1.2% |
Asthma |
1.2% |
Hyperlipidaemia |
1.1% |
Blood Cholesterol |
1.0% |
Hypercholesterolaemia |
0.9% |
Insomnia |
0.9% |
|
Weight Decreased |
21.6% |
Vomiting |
9.4% |
Blood Glucose Increased |
8.5% |
Nausea |
6.3% |
Weight Increased |
5.2% |
Drug Ineffective |
4.4% |
Pancreatitis |
4.3% |
Death |
4.1% |
Renal Failure Acute |
3.8% |
Pain |
3.7% |
Pneumonia |
3.7% |
Pruritus |
3.3% |
Myocardial Infarction |
3.1% |
Tremor |
3.1% |
Flushing |
2.7% |
Pulmonary Embolism |
2.6% |
Hypoglycaemia |
2.6% |
Rash |
2.6% |
Pancreatitis Acute |
2.5% |
Pyrexia |
2.5% |
|
Interacting |
Diabetes Mellitus |
21.6% |
Product Used For Unknown Indication |
13.8% |
Type 2 Diabetes Mellitus |
12.0% |
Diverticulitis |
10.2% |
Hypertension |
6.6% |
Venous Occlusion |
5.4% |
Acute Myocardial Infarction |
4.8% |
Depression |
3.6% |
Onychomycosis |
3.6% |
Drug Use For Unknown Indication |
3.0% |
Pyrexia |
2.4% |
Type 1 Diabetes Mellitus |
2.4% |
Latent Tuberculosis |
1.8% |
Upper Respiratory Tract Inflammation |
1.8% |
Anticoagulant Therapy |
1.2% |
Arthralgia |
1.2% |
Blood Cholesterol |
1.2% |
Diarrhoea |
1.2% |
Hypothyroidism |
1.2% |
Neuralgia |
1.2% |
|
Drug Interaction |
20.9% |
Hypoglycaemia |
11.6% |
Hypoglycaemic Coma |
11.6% |
Hypotension |
7.0% |
Syncope |
7.0% |
Medication Residue |
4.7% |
Pain In Extremity |
4.7% |
Palpitations |
4.7% |
Breast Cancer Metastatic |
2.3% |
Convulsion |
2.3% |
Death |
2.3% |
Glycosylated Haemoglobin Decreased |
2.3% |
Glycosylated Haemoglobin Increased |
2.3% |
Hypertension |
2.3% |
Lethargy |
2.3% |
Malaise |
2.3% |
Nausea |
2.3% |
Neutropenia |
2.3% |
Paraesthesia |
2.3% |
Potentiating Drug Interaction |
2.3% |
|